Copyright
©The Author(s) 1999.
World J Gastroenterol. Oct 15, 1999; 5(5): 408-416
Published online Oct 15, 1999. doi: 10.3748/wjg.v5.i5.408
Published online Oct 15, 1999. doi: 10.3748/wjg.v5.i5.408
Table 6 Expression of gastrin, c-myc, c-fos, rasp21 and AgNORs
| Group | n | gastrin positive (%) | c-myc positive (%) | c-fos positive (%) | rasp21 positive (%) | AgNORs (%) |
| Carcinoma tissue | 48 | 19 (39.6)b | 26 (54.2)b | 23 (47.9)b | 26 (54.2)b | 7.10 ± 1.48b |
| 3 cm mucosa | 48 | 2 (4.2) | 12 (25.0) | 9 (18.8) | 10 (20.8) | 3.65 ± 1.04c |
| 6 cm mucosa | 48 | 0 (0) | 7 (14.6) | 4 (803) | 6 (12.5) | 2.88 ± 0.73 |
| Normal | 10 | 0 (0) | 1 (10.0) | 1 (10.0) | 2 (20.0) | 2.85 ± 0.60 |
- Citation: He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma. World J Gastroenterol 1999; 5(5): 408-416
- URL: https://www.wjgnet.com/1007-9327/full/v5/i5/408.htm
- DOI: https://dx.doi.org/10.3748/wjg.v5.i5.408